Project Title: “Forewarned is Forearmed: Prediction of Migraine Attacks for Improved Patient Outcomes”
Nearly 1 billion people worldwide experience migraine, and the World Health Organization ranks migraine as second highest disease-causing disability. People with migraine suffer periodic, often unpredictable, attacks which may include severe headache, nausea, vomiting, sensitivity to light and sound, and dizziness.
Dr. Dumkrieger’s research will use wearable sensors as well as speech and cognitive function assessments to help predict migraine attacks. Accurate identification of a migraine in the pre-headache phase of an attack may lead to substantial improvements in patient management of migraine, including giving patients a greater sense of control, avoidance of factors that worsen migraines, and use of measures that reduce migraine attack symptoms and their impact.
Dr. Dumkrieger is a research fellow and assistant professor of neurology at the Mayo Clinic Arizona.
This research is funded by Amgen through the American Brain Foundation, in collaboration with the American Academy of Neurology.